Related Experiment Video
Updated: Jan 2, 2026
06:57
Transaxillary First Rib Resection for Treatment of the Thoracic Outlet Syndrome
Published on: September 13, 2020
3.8K
Robotic First Rib Resection for Thoracic Outlet Syndrome
Farid Gharagozloo1, Mark Meyer2, Barbara Tempesta1
1Center for Advanced Thoracic Surgery, Global Robotics Institute, Advent Health, University of Central Florida, Celebration, FL.
Surgical Technology International
|December 11, 2019
Summary
Robotic first rib resection effectively treats Thoracic Outlet Syndrome (TOS), offering excellent symptom relief for neurogenic and venous conditions. This minimally invasive approach shows no neurovascular complications and high patient recovery rates.
Area of Science:
- Minimally Invasive Surgery
- Thoracic Surgery
- Vascular Surgery
Background:
- Thoracic Outlet Syndrome (TOS) is a condition often requiring surgical intervention.
- First rib resection is a primary surgical treatment for TOS.
- Robotic surgery offers potential advantages in minimally invasive thoracic procedures.
Purpose of the Study:
- To report the experience and technique of robotic first rib resection for Thoracic Outlet Syndrome.
- To evaluate the efficacy and safety of robotic first rib resection in patients with TOS.
Main Methods:
- Robotic transthoracic first rib resection was performed on patients diagnosed with TOS.
- Magnetic Resonance Angiography (MRA) with maneuvers was used for definitive TOS diagnosis.
- The procedure involved disarticulation of the costo-sternal joint.
Main Results:
- 67 patients underwent robotic first rib resection for Neurogenic TOS or Paget-Schroetter Syndrome (PSS).
- QuickDASH scores significantly improved in Neurogenic TOS patients (p<0.0001).
- 100% subclavian vein patency was achieved in PSS patients at 24 months follow-up, with 32% requiring venoplasty.
Conclusions:
- Robotic transthoracic first rib resection is a safe and effective minimally invasive treatment for TOS.
- The procedure leads to excellent symptom relief and high recovery rates.
- No neurovascular complications or mortality were observed.
